Impact of ERCC1, XPF and DNA Polymerase β Expression on Platinum Response in Patient-Derived Ovarian Cancer Xenografts

Platinum resistance is an unmet medical need in ovarian carcinoma. Molecular biomarkers to predict the response to platinum-based therapy could allow patient stratification and alternative therapeutic strategies early in clinical management. Sensitivity and resistance to platinum therapy are partial...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancers (Basel)
Asıl Yazarlar: Guffanti, Federica, Alvisi, Maria Francesca, Caiola, Elisa, Ricci, Francesca, De Maglie, Marcella, Soldati, Sabina, Ganzinelli, Monica, Decio, Alessandra, Giavazzi, Raffaella, Rulli, Eliana, Damia, Giovanna
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7564949/
https://ncbi.nlm.nih.gov/pubmed/32847049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12092398
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller